|
Nov 1
|
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
|
|
Oct 31
|
AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday
|
|
Oct 31
|
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
|
|
Oct 31
|
AbbVie announces 2025 dividend increase of 5.8% to $1.64 from $1.55 per share
|
|
Oct 31
|
5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
|
|
Oct 31
|
AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong Growth in Ex-Humira Platform and ...
|
|
Oct 31
|
Q3 2024 AbbVie Inc Earnings Call
|
|
Oct 30
|
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
|
|
Oct 30
|
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
|
|
Oct 30
|
AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View
|
|
Oct 30
|
Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics
|
|
Oct 30
|
AbbVie Raises Full-Year Outlook Following Third-Quarter Beat
|
|
Oct 30
|
AbbVie Stock Rises After Earnings Beat, Dividend Hike
|
|
Oct 30
|
AbbVie (ABBV) Surpasses Q3 Earnings and Revenue Estimates
|
|
Oct 30
|
AbbVie raises profit forecast as CEO cites business "momentum"
|
|
Oct 30
|
AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq
|
|
Oct 30
|
AbbVie: Q3 Earnings Snapshot
|
|
Oct 30
|
AbbVie Reports Third-Quarter 2024 Financial Results
|
|
Oct 30
|
3 Dividend Growth Stocks to Buy and Never Sell
|
|
Oct 29
|
AbbVie to Acquire Aliada Therapeutics for $1.4 Billion, Expanding Alzheimer's Pipeline
|